Board of Directors of Revenio has established Technology and Integration Committees

The Board of Directors of Revenio Group Corporation has decided to establish a Technology Committee and an Integration Committee effective as of 10 June 2026.

In accordance with the charter of the Technology Committee, the Board elected from among its members Marc Abitbol (Chair), Anat Loewenstein and Bill Östman as its members. In accordance with the charter of the Integration Committee, Marc Abitbol (Chair), Arne Boye Nielsen, Nicklas Hansen and Charles Vilgrain were elected as members.

The Board also updated the composition of the Audit Committee in accordance with its charter and elected Nicklas Hansen as a member of the Audit Committee. Bill Östman will step down from his position as a member of the Audit Committee.

For further information, please contact
CEO Jouni Toijala
+358 50 484 0085
[email protected]

Distribution
Nasdaq Helsinki Oy
Financial Supervisory Authority (FIN-FSA)
Main media
www.reveniogroup.fi/en

Revenio Group in brief
Revenio is a leading turnkey solutions provider in the global eye care market. The group offers fast, user-friendly, and reliable tools for diagnosing a wide variety of eye diseases. Revenio’s solutions include e.g. tonometers, fundus imaging devices, optical coherence tomography (OCT), perimeters, multimodal devices, refraction systems, and software solutions under iCare and Visionix. 

In May 2026, Revenio joined forces with Visionix, creating the most innovative, creative and comprehensive entity serving eye care professionals across optometry, optical retail and ophthalmology. In 2025, the Group’s net sales totaled EUR 109.7 million, with an operating profit of EUR 25.4 million. Revenio Group Corporation is listed on Nasdaq Helsinki with the trading code REG1V.